Skip to menu Skip to content Skip to footer
Dr Germain Fernando
Dr

Germain Fernando

Email: 

Overview

Background

Dr Fernando's current research interests include developing needle-free, pain-free, skin patch vaccines. Influenza and human papilloma virus vaccines are used as model vaccines in these studies.

Dr Germain Fernando completed PhD at the University of Arizona, USA, and did post-doctoral research at the Baylor College of Medicine, Houston, Texas, USA, before joining the University of Queensland in 1989. He has been working in the field of vaccinology for the last 28 years. He has a H-Index of 36.

He is a Senior Consultant at Vaxxas Pty. Ltd, Brisbane, Australia

Publications and Citation Metrics are available at the following website:

http://www.researcherid.com/rid/C-3733-2009

Availability

Dr Germain Fernando is:
Available for supervision
Media expert

Fields of research

Qualifications

  • Bachelor (Honours) of Science (Advanced), Institution to be confirmed
  • Doctor of Philosophy, Arizona State University

Research interests

  • Vaccinations using a novel needle-free, pain-free, skin patch.

    Although effective vaccines are available for combating diseases such as flu and cervical cancer, some people are reluctant to get vaccinated because of the fear of the needle. The needle and syringe first invented in 1853 is still being used because of the convenience to the person administering the vaccine. However this method has many disadvantages: Fear of the needle and the pain of injection, especially among children. Furthermore injection into muscle is less efficient than delivering the vaccine directly to immunologically active cells in the skin. We have designed a skin patch to overcome these disadvantages. We have recently published data to show potent immunity can be induced using very low doses of vaccine delivered by the skin patch. Reference: Fernando et al PLoS One 2010 April 21:5(4), e 10266.

Works

Search Professor Germain Fernando’s works on UQ eSpace

112 works between 1981 and 2025

21 - 40 of 112 works

Featured

2009

Journal Article

Epithelial expression of human papillomavirus type 16 E7 protein results in peripheral CD8 T-cell suppression mediated by CD4(+)CD25(+) T cells

Narayan, S., Choyce, A., Linedale, R., Saunders, N. A., Dahler, A., Chan, E., Fernando, G. J., Frazer, I. H. and Leggatt, G. R. (2009). Epithelial expression of human papillomavirus type 16 E7 protein results in peripheral CD8 T-cell suppression mediated by CD4(+)CD25(+) T cells. European Journal of Immunology, 39 (2), 481-490. doi: 10.1002/eji.200838527

Epithelial expression of human papillomavirus type 16 E7 protein results in peripheral CD8 T-cell suppression mediated by CD4(+)CD25(+) T cells

Featured

2008

Other Outputs

Coating Method

Kendall, Mark, Fernando, Germain, Chen, Xianfeng and Prow, Tarl (2008). Coating Method. WO2009/079712.

Coating Method

Featured

2008

Journal Article

TLR7 stimulation augments T effector-mediated rejection, of skin expressing neo-self antigen in keratinocytes

Zhong, Jie, Usriansyah Usriansyah, Rachel De Kluyver, Leggatt, Graham R., Fernando, Germain J. and Frazer, Ian H. (2008). TLR7 stimulation augments T effector-mediated rejection, of skin expressing neo-self antigen in keratinocytes. European Journal of Immunology, 38 (1), 73-81. doi: 10.1002/eji.200737599

TLR7 stimulation augments T effector-mediated rejection, of skin expressing neo-self antigen in keratinocytes

Featured

2007

Journal Article

Secondary immunisation with high-dose heterologous peptide leads to CD8 T cell populations with reduced functional avidity

Narayan, S., Choyce, A., Fernando, G. J. P. and Leggatt, G. R. (2007). Secondary immunisation with high-dose heterologous peptide leads to CD8 T cell populations with reduced functional avidity. European Journal of Immunology, 37 (2), 406-415. doi: 10.1002/eji.200535688

Secondary immunisation with high-dose heterologous peptide leads to CD8 T cell populations with reduced functional avidity

Featured

2006

Journal Article

Overcoming original antigenic sin to generate new CD8 T cell IFN-gamma responses in an antigen-experienced host

Liu, Xiao Song, Dyer, Joanne, Leggatt, Graham R., Fernando, Germain J. P., Zhong, Jie, Thomas, Ranjeny and Frazer, Ian H. (2006). Overcoming original antigenic sin to generate new CD8 T cell IFN-gamma responses in an antigen-experienced host. Journal of Immunology, 177 (5), 2873-2879. doi: 10.4049/jimmunol.177.5.2873

Overcoming original antigenic sin to generate new CD8 T cell IFN-gamma responses in an antigen-experienced host

Featured

2005

Journal Article

The role of CD4 T help in multiple vaccinations when using minimal CD8 T cell epitope peptides

Khammanivong, V., Peters, T., Andrews, M., Leggatt, G. R., Frazer, I. H. and Fernando, G. J. (2005). The role of CD4 T help in multiple vaccinations when using minimal CD8 T cell epitope peptides. Tissue Antigens, 66 (5), 415-415.

The role of CD4 T help in multiple vaccinations when using minimal CD8 T cell epitope peptides

Featured

2005

Journal Article

Transgenic expression of a viral oncoprotein exclusively in K14(+) epithelial cells results in peripheral but not central CD8 T cell tolerance

Leggatt, G. R., Saunders, N., Dahler, A., Fernando, G. J., Matsumoto, K., Narayan, S., Linedale, R., Choyce, A. and Frazer, I. H. (2005). Transgenic expression of a viral oncoprotein exclusively in K14(+) epithelial cells results in peripheral but not central CD8 T cell tolerance. Tissue Antigens, 66 (5), 475-476.

Transgenic expression of a viral oncoprotein exclusively in K14(+) epithelial cells results in peripheral but not central CD8 T cell tolerance

Featured

2004

Journal Article

Functional memory CD8+ T cells can be generated in vivo without evident T help

Andrews, Melanie R., Peters, Tania, Khammanivong, Vithagna, Leggatt, Graham R., Frazer, Ian H. and Fernando, Germain J. P. (2004). Functional memory CD8+ T cells can be generated in vivo without evident T help. Vaccine, 23 (6), 739-742. doi: 10.1016/j.vaccine.2004.07.027

Functional memory CD8+ T cells can be generated in vivo without evident T help

Featured

2004

Journal Article

Human growth hormone (hGH) presented by K14hGH-transgenic skin grafts induces a strong immune response but no graft rejection

Zhong, J., Matsumoto, K., De Kluyver, R., Fernando, G. J. P., Leggatt, G. R. and Frazer, I. H. (2004). Human growth hormone (hGH) presented by K14hGH-transgenic skin grafts induces a strong immune response but no graft rejection. Journal of Investigative Dermatology, 123 (6), A113-A113.

Human growth hormone (hGH) presented by K14hGH-transgenic skin grafts induces a strong immune response but no graft rejection

Featured

2004

Journal Article

Tumour susceptibility to innate and adaptive immunotherapy changes during tumour maturation

Stewart, Trina J., Fernando, Germain J. P., Frazer, Ian H. and Leggatt, Graham R. (2004). Tumour susceptibility to innate and adaptive immunotherapy changes during tumour maturation. Immunology and Cell Biology, 82 (5), 455-461. doi: 10.1111/j.0818-9641.2004.01273.x

Tumour susceptibility to innate and adaptive immunotherapy changes during tumour maturation

Featured

2004

Journal Article

ISCOMATRIX (TM) adjuvant: An adjuvant suitable for use in anticancer vaccines

Stewart, Trina J., Drane, Debbie, Malliaros, Jim, Elmer, Heidi, Malcolm, Karen M., Cox, John C., Edwards, Stirling J., Frazer, Ian H. and Fernando, Germain J. P. (2004). ISCOMATRIX (TM) adjuvant: An adjuvant suitable for use in anticancer vaccines. Vaccine, 22 (27-28), 3738-3743. doi: 10.1016/j.vaccine.2004.03.026

ISCOMATRIX (TM) adjuvant: An adjuvant suitable for use in anticancer vaccines

Featured

2004

Journal Article

Erratum: IL-10 Mediates Suppression of the CD8 T Cell IFN-γ Response to a Novel Viral Epitope in a Primed Host (Journal of Immunology (2003) 171 (4765-4772))

Liu, X. S., Xu, Y., Zhao, W. M., Fernando, G. J. P., Leggatt, G. R. and Frazer, I. H. (2004). Erratum: IL-10 Mediates Suppression of the CD8 T Cell IFN-γ Response to a Novel Viral Epitope in a Primed Host (Journal of Immunology (2003) 171 (4765-4772)). Journal of Immunology, 172 (2), 1311-1311. doi: 10.4049/jimmunol.172.2.1311-a

Erratum: IL-10 Mediates Suppression of the CD8 T Cell IFN-γ Response to a Novel Viral Epitope in a Primed Host (Journal of Immunology (2003) 171 (4765-4772))

Featured

2004

Journal Article

Human growth hormone presented by K14hGH-transgenic skin grafts induces a strong immune response but no graft rejection

Zhong, Jie, Matsumoto, Koji, De Kluyver, Rachel, Fernando, Germain J. P., Leggatt, Graham R. and Frazer, Ian H. (2004). Human growth hormone presented by K14hGH-transgenic skin grafts induces a strong immune response but no graft rejection. Immunology and Cell Biology, 82 (6), 577-586. doi: 10.1111/j.1440-1711.2004.01292.x

Human growth hormone presented by K14hGH-transgenic skin grafts induces a strong immune response but no graft rejection

Featured

2004

Journal Article

Impaired Antigen Presentation and Effectiveness of Combined Active/Passive Immunotherapy for Epithelial Tumors

Matsumoto, K., Leggatt, G. R., Zhong, J., Liu, X. S., De Kluyver, R. L., Peters, T., Fernando, G. J. P., Liem, A., Lambert, P. F. and Frazer, I. H. (2004). Impaired Antigen Presentation and Effectiveness of Combined Active/Passive Immunotherapy for Epithelial Tumors. Journal of the National Cancer Institute, 96 (21), 1611-1619. doi: 10.1093/jnci/dhj301

Impaired Antigen Presentation and Effectiveness of Combined Active/Passive Immunotherapy for Epithelial Tumors

Featured

2003

Journal Article

IL-10 Mediates Suppression of the CD8 T Cell IFN-γ Response to a Novel Viral Epitope in a Primed Host

Liu, Xiao Song, Xu, Yan, Hardy, Lani, Khammanivong, Vithagna, Zhao, Weiming M., Fernando, Germain J. P., Leggatt, Graham R. and Frazer, Ian H. (2003). IL-10 Mediates Suppression of the CD8 T Cell IFN-γ Response to a Novel Viral Epitope in a Primed Host. Journal of Immunology, 171 (9), 4765-4772. doi: 10.4049/jimmunol.171.9.4765

IL-10 Mediates Suppression of the CD8 T Cell IFN-γ Response to a Novel Viral Epitope in a Primed Host

Featured

2003

Journal Article

Inhibition of early tumor growth requires Jα18-positive (natural killer T) cells

Stewart, Trina J., Smyth, Mark J., Fernando, Germain J. P., Frazer, Ian H. and Leggatt, Graham R. (2003). Inhibition of early tumor growth requires Jα18-positive (natural killer T) cells. Cancer Research, 63 (12), 3058-3060.

Inhibition of early tumor growth requires Jα18-positive (natural killer T) cells

Featured

2003

Journal Article

Paucity of functional CTL epitopes in the E7 oncoprotein of cervical cancer associated human papillomavirus type 16

Khammanivong, Vithagna, Liu, Xiao Song, Liu, Wen Jun, Rodda, Stuart J., Leggatt, Graham R., Tindle, Robert W., Frazer, Ian H. and Fernando, Germain J. P. (2003). Paucity of functional CTL epitopes in the E7 oncoprotein of cervical cancer associated human papillomavirus type 16. Immunology and Cell Biology, 81 (1), 1-7. doi: 10.1046/j.1440-1711.2003.01130.x

Paucity of functional CTL epitopes in the E7 oncoprotein of cervical cancer associated human papillomavirus type 16

Featured

2002

Journal Article

Antigen-specific CD4+ T-Cell Help Is Required to Activate a Memory CD8+ T Cell to a Fully Functional Tumor Killer Cell

Gao, Feng Guang, Khammanivong, Vithagna, Liu, Wen Jun, Leggatt, Graham R., Frazer, Ian H. and Fernando, Germain J. P. (2002). Antigen-specific CD4+ T-Cell Help Is Required to Activate a Memory CD8+ T Cell to a Fully Functional Tumor Killer Cell. Cancer Research, 62 (22), 6438-6441.

Antigen-specific CD4+ T-Cell Help Is Required to Activate a Memory CD8+ T Cell to a Fully Functional Tumor Killer Cell

Featured

2002

Journal Article

Codon modified human papillomavirus type 16 E7 DNA vaccine enhances cytotoxic T-lymphocyte induction and anti-tumour activity

Liu, Wen Jun, Gao, Fengguang, Zhao, Kong Nan, Zhao, Weiming, Fernando, Germain J. G., Thomas, Ranjeny and Frazer, Ian H. (2002). Codon modified human papillomavirus type 16 E7 DNA vaccine enhances cytotoxic T-lymphocyte induction and anti-tumour activity. Virology, 301 (1), 43-52. doi: 10.1006/viro.2002.1584

Codon modified human papillomavirus type 16 E7 DNA vaccine enhances cytotoxic T-lymphocyte induction and anti-tumour activity

Featured

2002

Journal Article

The number of long-lasting functional memory CD8(+) T cells generated depends on the nature of the initial nonspecific stimulation

Fernando, G. J. P., Khammanivong, V., Leggatt, G. R., Liu, W. J. and Frazer, I. H. (2002). The number of long-lasting functional memory CD8(+) T cells generated depends on the nature of the initial nonspecific stimulation. European Journal of Immunology, 32 (6), 1541-1549. doi: 10.1002/1521-4141(200206)32:63.0.CO;2-S

The number of long-lasting functional memory CD8(+) T cells generated depends on the nature of the initial nonspecific stimulation

Funding

Past funding

  • 2018 - 2021
    Needle free delivery of dengue and Zika vaccines to the skin
    NHMRC Development Grant
    Open grant
  • 2009 - 2011
    Nanopatch immunisation against pandemic Novel A (H1N1) influenza virus 09: potent immunity at a reduced dose
    NHMRC Urgent Research - H1N1 Influenza 09
    Open grant
  • 2009 - 2011
    Nanopatch immunisation against pandemic influenza: improved immune responses at a reduced dose.
    NHMRC Project Grant
    Open grant
  • 2005
    NHMRC Equipment Grant : Estimation of drugs, peptides and metabolites using HPLC-Mass-spectrometry-microdialysis
    NHMRC Equipment Grant
    Open grant
  • 2005 - 2006
    Optimising Immunotherapy in Tumour Antigen Experienced Host
    Queensland Cancer Fund
    Open grant
  • 2004 - 2005
    NHMRC_Equipment Grant _HLTH_CICR_Med SCD
    NHMRC Equipment Grant
    Open grant
  • 2004 - 2006
    The Role Of CD4+ T Cells In The Tumour Killing By CD8+ Memory T Cells
    NHMRC Project Grant
    Open grant
  • 2002 - 2004
    Optimising immunity towards cancers by vaccination
    NHMRC Project Grant
    Open grant
  • 2000 - 2002
    The role CD4++ T-helper cells in the generation, maintenance and activation of a long lasting antitumour CTL effect
    NHMRC Project Grant
    Open grant
  • 2000
    The role of T-help in maintenance of memory cytotoxic T cells.
    ARC Australian Research Council (Small grants)
    Open grant
  • 1998 - 1999
    Comparison of Efficacy of oil Based Adjuvants Versus Water Based Ajuvants in Cervical Cancer Vaccines
    Princess Alexandra Hospital R&D Foundation
    Open grant
  • 1997 - 1999
    T help as a determinant of effector CTL function in immunotherapy
    NHMRC Project Grant
    Open grant
  • 1997
    The role of cytokines in cervical cancer regression
    Princess Alexandra Hospital R&D Foundation
    Open grant
  • 1996
    Improved vaccines against cervical cancers
    Princess Alexandra Hospital R&D Foundation
    Open grant
  • 1996
    The role of t-help in the CTL induced regression of tumours
    Mayne Bequest Fund
    Open grant
  • 1995
    Optimising immunity towards tumours by vaccination
    Cancer Bequest Fund
    Open grant

Supervision

Availability

Dr Germain Fernando is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Available projects

  • Development of needle-free pain-free skin patch vaccines

    1). Delivering of vaccines using a novel skin patch that is needle-free and pain-free which induces potent immune responses. Study of mechanisms.

    2). Developing Universal Influenza Vaccines that protect people from new strains of virus.

    3). Translating the skin patch vaccine delivery system from animal models to human clinical testing.

Media

Enquiries

Contact Dr Germain Fernando directly for media enquiries about:

  • Anti-cancer Vaccines
  • Antibody
  • Biochemistry
  • Drug Delivery
  • Immunisation
  • Immunology
  • Influenza vaccines
  • Lipid Chemistry
  • Lipoproteins
  • Medical Devices
  • Nanopatch
  • Needle-free vaccination
  • Papillomavirus Vaccines
  • Protein Chemistry
  • Skin - vaccinations
  • Systems Vaccinology
  • T-Cells
  • Vaccination
  • Vaccine Adjuvants
  • Vaccine delivery
  • Vaccines
  • Vaccines and genes
  • Viral Vaccines

Need help?

For help with finding experts, story ideas and media enquiries, contact our Media team:

communications@uq.edu.au